← All companies

Veracyte

Healthcare & Life Sci

Company overview

Veracyte makes molecular diagnostic tests that help doctors and patients make cancer treatment decisions. Its tests include Afirma for thyroid nodules, Decipher for bladder and prostate cancer, Prosigna for breast cancer risk, and TrueMRD for cancer monitoring. Veracyte is based in South San Francisco, United States.

Veracyte went public in October 2013 on the Nasdaq Global Market, under ticker VCYT. Its team of more than 800 people has helped guide care decisions for over 900,000 patients. That matters: each test result feeds directly into a treatment choice, so growth here tracks patients tested, not just products sold. Historically, the median salary is ~$163,500. Veracyte is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
South San Francisco, United States

Filters

Create your account

Create an account to save jobs and track applications.